Wells Fargo & Company SPYRE THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
34,409
Previous 30,035 14.56%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
4,374 Added 14.56%
34,409 $0
Q1 2025

May 13, 2025
BUY
N/A
5,317 Added 21.51%
30,035 $0
Q4 2024

Feb 12, 2025
BUY
N/A
6,908 Added 38.79%
24,718 $0
Q3 2024

Nov 13, 2024
BUY
N/A
635 Added 3.7%
17,810 $0
Q2 2024

Aug 13, 2024
BUY
N/A
14,933 Added 666.06%
17,175 $0
Q1 2024

May 10, 2024
BUY
N/A
2,219 Added 9647.83%
2,242 $0
Q4 2023

Feb 09, 2024
BUY
N/A
1 Added 4.55%
23 $0
Q3 2023

Nov 13, 2023
BUY
N/A
22 New
22 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email